AAD
Author: Willhemenia Loremipsum Special session: Lorem ipsum dolor sit amet Category: Lorem ipsum View all results

Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Management of Nail Warts

Description

The presentation focuses on the management of nail warts, which are common tumors of the nail unit, emphasizing the need for differential diagnosis, particularly to rule out conditions like squamous cell carcinoma (SCC). The speaker explores various treatment options, detailing several modalities, including topical treatments like podophylline and salicylic acid, as well as procedural options such as electrochemotherapy and intralesional injections of bleomycin. The speaker highlights the importance of patient relationships and adherence to treatment for efficacy, suggesting that aggressive treatments do not always correlate with better outcomes. A case example is presented to illustrate the importance of histological confirmation through biopsy before treatment, with bleomycin identified as a first-line treatment option due to its favorable cure rates. Evidence from studies suggests that the number of treatment sessions impacts success rates significantly. Furthermore, electrochemotherapy combining bleomycin with electroporation shows promising results. The presentation concludes by stressing the importance of individualized treatment plans and effective communication with patients, noting that a one-size-fits-all solution for nail warts does not exist.

View more

Conclusions

  • Intralesional bleomycin is effective as a first-line treatment for periungual warts, especially with multiple sessions.
  • Electrochemotherapy using bleomycin and electroporation shows a significantly higher cure rate than bleomycin alone.
  • Aggressive treatment approaches do not necessarily correlate with better outcomes for periungual warts.
  • Establishing a strong doctor-patient relationship promotes adherence to treatment, which is crucial for successful wart management.
  • Patient biopsies are important to confirm the diagnosis and provide assurance of treatment efficacy.
  • The use of keratolytics can prepare the lesion for future treatments and should be part of the management plan.
  • Substantial variability exists in the effectiveness of treatment options for periungual warts, and a single 'gold standard' treatment does not exist.
  • Continuous follow-up is essential as treatment responses can change over time, and recurrence is common in periungual warts.
  • Tosti A, Piraccini BM. Warts of the nail unit: surgical and nonsurgical approaches. Dermatol Surg 2001: 27: 235-239.
  • Kirnbauer R, Lenz P, Okun MM. Human papilloma virus. In: Bolognia J, Jorizzo JL, Rapini RP, eds. Dermatology. Spain: Mosby, 2007: 1183-1198.
  • Zaiac MN, Weiss E. Mohs micrographic surgery of the nail unit and squamous cell carcinoma. Dermatol Surg 2001: 27:246-251.
  • Thomas L, Zook EG, Haneke E, Drapé JL, Baran R. Tumors of the Nail Apparatus and Adjacent Tissues. In Baran R, de Berker DAR, Holzberg M, Thomas L. Diseases of the Nails and their Management. 4th ed. Oxford: Wiley; 2012. p.657-61.
  • Finkel ML, Finkel DJ. Warts among meat handlers. Arch Dermatol 1984: 120: 1314-1317.
  • Veasey JV. Use of imiquimod in the treatment of chronic periungual warts. Surg Cosmet Dermatol. Rio de Janeiro v.11 n.4 ouc-dec. 2019 p. 325-9.
  • British Association of Dermatologists' guidelines for the management of cutaneous warts 2014. Br J Dermatol. 2014;171(4):696-712.
  • Herschthal J, McLeod MP, Zaiac M. Management of ungual warts. Dermatol Ther. 2012;25(6):545-50.
  • Poppens M, Davis J. Intralesional cidofovir for the treatment of recalcitrant periungual warts. J Dermatolog Treat. 2023 Dec;34(1):2154569.
  • Rutnin S, Namasondhi A, Pomsoong C, Kositkuljorn C, Anuntrangsee T, Thadanipon K. Intralesional Measles, Mumps, Rubella Vaccine versus Tuberculin Purified Protein Derivative Injections in the Treatment of Palmoplantar and Periungual Warts: A Double-Blind Randomized Controlled Trial. Dermatology. 2023;239(1):109-115.
  • Starace M, Waśkiel-Burnat A, Bruni F, Alessandrini A, Dika E, Piraccini MB, Iorizzo M. Combination of topical fluorouracil and salicylic acid as a therapeutic option for recalcitrant warts of the nail unit. J Eur Acad Dermatol Venereol. 2023 Mar;37(3):e410-e411.
  • Shin JO, Son JH, Lee J, Kim HS, Ko HC, Kim BS, Kim MB, Shin K. Nonavalent human papilloma virus vaccine for the treatment of multiple recalcitrant warts: An open-label study. J Am Acad Dermatol. 2022 Apr;86(4):940-941.
  • Jiang F, Shao J, Chen L, Yang N, Liu J, Li Z. Successful treatment of periungual warts with local hyperthermia: report of two cases. Clin Cosmet Investig Dermatol. 2022 Dec 6;15:2617-2620.
  • Taneja G, Hazarika N, Bhatia R. Effectiveness of autoinoculation in viral warts: A single arm, open-label, and clinical trial. Dermatol Ther. 2020 Nov;33(6):e14122.
  • Priya A, Adil M, Amin SS, Mohtashim M, Bansal R, Alam M. Intralesional Vitamin D3 in Recalcitrant Palmoplantar and Periungual Warts: A Prospective, Observational Study. Acta Dermatovenerol Croat. 2019 Dec;27(4):215-224.
  • Di Chiacchio NG, Di Chiacchio N, Criado PR, Brunner CHM, Suaréz MVR, Belda Junior W. Ungual warts: comparison of treatment with intralesional bleomycin and electroporation in terms of efficacy and safety. J Eur Acad Dermatol Venereol. 2019 Dec;33(12):2349-2354.